土壤脲酶活性两种测定方法的比较

利用比色法和扩散法对金强河地区和甘肃农业大学校园内的土壤脲酶活性进行了分析。结果表明：比色法和扩散法测定的土壤脲酶活性平均值分别为（0．531±0．207）mg／g和（0．446±0．204）mg／g,两种测定方法的结果和变异系数差异均不显著（P〉0．05）。但从试验操作方面考虑,扩散法操作比较简单、所用药品种类少、时间短,是一种比较可行的土壤脲酶活性测定方法。     

Pharmacokinetics of sanguinarine,chelerythrine, and their metabolites in broiler chickens following oral and intravenous administration

Sanguinarine (SA) and chelerythrine (CHE) are the main active components of the phytogenic livestock feed additive, Sangrovit®. However, little information is available on the pharmacokinetics of Sangrovit® in poultry. The goal of this work was to study the pharmacokinetics of SA, CHE, and their metabolites, dihydrosanguinarine (DHSA) and dihydrochelerythrine (DHCHE), in 10 healthy female broiler chickens following oral (p.o.) administration of Sangrovit® and intravenous (i.v.) administration of a mixture of SA and CHE. The plasma samples were processed using two different simple protein precipitation methods because the parent drugs and metabolites are stable under different pH conditions. The absorption and metabolism of SA following p.o. administration were fast, with half‐life (t_1/2) values of 1.05 ± 0.18 hr and 0.83 ± 0.10 hr for SA and DHSA, respectively. The maximum concentration (C_max) of DHSA (2.49 ± 1.4 μg/L) was higher that of SA (1.89 ± 0.8 μg/L). The area under the concentration vs. time curve (AUC) values for SA and DHSA were 9.92 ± 5.4 and 6.08 ± 3.49 ng/ml hr, respectively. Following i.v. administration, the clearance (CL) of SA was 6.79 ± 0.63 (L·h^?1·kg^?1) with a t_1/2 of 0.34 ± 0.13 hr. The AUC values for DHSA and DHCHE were 7.48 ± 1.05 and 0.52 ± 0.09 (ng/ml hr), respectively. These data suggested that Sangrovit® had low absorption and bioavailability in broiler chickens. The work reported here provides useful information on the pharmacokinetic behavior of Sangrovit® after p.o. and i.v. administration in broiler chickens, which is important for the evaluation of its use in poultry.     

Ultra‐frequent HRAS p.Q61R somatic mutation in canine acanthomatous ameloblastoma reveals pathogenic similarities with human ameloblastoma

Ameloblastoma is a locally aggressive odontogenic tumour that occurs in humans and dogs. Most ameloblastomas (AM) in humans harbour mutually‐exclusive driving mutations in BRAF, HRAS, KRAS, NRAS or FGFR2 that activate MAPK signalling, and in SMO that activates Hedgehog signalling. The remarkable clinical and histological similarities between canine acanthomatous ameloblastoma (CAA) and AM suggest they may harbour similar driving mutations. In this study, aimed at characterizing the mutational status of SMO, BRAF, HRAS, KRAS, NRAS and FGFR2 in CAA, we used RNA sequencing, Sanger sequencing and restriction fragment length polymorphism assays to demonstrate that 94% of CAA (n = 16) harbour a somatic HRAS p.Q61R mutation. The similarities in MAPK‐activating mutational profiles between CAA and AM implicate conserved molecular mechanisms of tumorigenesis, thus, qualifying the dog as a potentially useful model of disease. Given the relevance of RAS mutations in the pathogenesis of odontogenic tumours and other types of cancer, the results of this study are of comparative, translational, and veterinary value.     

糖原合成酶激酶3β对奶牛乳腺上皮细胞增殖及细胞周期的影响

本试验通过向纯化的奶牛乳腺上皮细胞中添加不同浓度（0（对照组）、10、20、40 mmol/L）的糖原合成酶激酶3β（glycogen synthase kinase 3β,GSK3β）特异性蛋白抑制剂氯化锂（Licl）,作用细胞24 h,研究其对奶牛乳腺上皮细胞增殖及细胞周期的影响,并利用qRT-PCR和Western blotting分别检测不同浓度Licl对奶牛乳腺上皮细胞中GSK3β、细胞周期蛋白D1（Cyclin D1） mRNA水平及GSK3β、磷酸化GSK3β （p-GSK3β）、Cyclin D1蛋白水平表达的影响。结果显示,Licl能促进奶牛乳腺上皮细胞的增殖活性,Licl抑制GSK3β后促进奶牛乳腺上皮细胞增殖的最佳浓度为20 mmol/L。与对照组相比,添加Licl后GSK3β蛋白表达受到抑制,p-GSK3β蛋白表达上调,同时提高了Cyclin D1蛋白表达。表明GSK3β对于奶牛乳腺上皮细胞增殖的能力是负调控因子,失活的GSK3β通过Cyclin D1途径促进细胞周期的进行。     

Pharmacokinetics and bioavailability of valnemulin in broiler chickens

Wang, R., Yuan, L.G., He, L.M., Zhu, L.X., Luo, X.Y., Zhang, C.Y., Yu, J.J., Fang, B.H., Liu, Y.H. Pharmacokinetics and bioavailability of valnemulin in broiler chickens. J. vet. Pharmacol. Therap. 34 , 247–251. The objective of this study was to investigate the pharmacokinetics and bioavailability of valnemulin in broiler chickens after intravenous (i.v.), intramuscular (i.m.) and oral administrations of 10 mg/kg body weight (bw). Plasma samples were analyzed by high‐performance liquid chromatography–tandem mass spectrometry (HPLC‐MS/MS). Pharmacokinetic characterization was performed by non‐compartmental analysis using WinNonlin program. After intravenous administration, distribution was wide with the volume of distribution based on terminal phase(V_z) of 4.27 ± 0.99 L /kg. Mean valnemulin t_1/2β(h), Cl_β(L /h /kg), V_ss (L /kg) and AUC_(0–∞)(μg·h /mL) values were 2.85, 0.99, 2.72 and 10.34, respectively. After intramuscular administration, valnemulin was rapidly absorbed with a C_max of 2.2 μg/mL achieved at 0.43 h (t_max), and the absolute bioavailability (F) was 88.81%; and for the oral route the same parameters were 0.66 ± 0.15 μg/mL, 1.54 ± 0.27 h and 74.42%. A multiple‐peak phenomenon was present after oral administration. The plasma profile of valnemulin exhibited a secondary peak during 2–6 h and a tertiary peak at 32 h. The favorable PK behavior, such as the wide distribution, slow elimination and acceptable bioavailability indicated that it is likely to be effective in chickens.     

Effects of Hormonal Supplementation on Nuclear Maturation and Cortical Granules Distribution of Canine Oocytes During Various Reproductive Stages

The aim of this study was to evaluate the effects of hCG, progesterone and oestradiol supplementation on nuclear and cytoplasmic maturation of canine oocytes cultured for 24, 48, 72 and 96 h. Oocytes obtained from 18 healthy bitches were divided into three groups according to their reproductive status (follicular, luteal and anoestrus stages) and cultured in TCM 199 + 25 UI/ml of hCG + 1 μg/ml of progesterone + 1 μg/ml of 17‐β oestradiol or without hormonal supplementation (control) for different periods. Then, they were stained with FITC‐LCA‐Hoescht for chromatin configuration and cortical granules distribution and evaluated under an epifluorescence microscope. Culture time and the influence of different stages of the oestrous cycle were also evaluated. The present study demonstrated that there was no significant difference among the reproductive stages. With regards to culture medium, only oocytes from the supplemented medium were able to complete meiosis; however, significant difference was only noticed in the percentage of MI stage oocytes (p < 0.05) in the follicular and luteal group at 72 h of culture. Most oocytes in germinal vesicle, germinal vesicle breakdown and metaphase I stage had cortical granules distributed throughout the cytoplasm (immature pattern), irrespective of the culture period (p < 0.05). Cortical granules distributed immediately beneath the plasma membrane (mature) was only observed in metaphase II stage oocytes, but not all of them presented matured cytoplasm. Our results reveal that cortical granules distribution in canine oocytes matured in vitro did not progressed in correspondence with nuclear stage changes and are in accordance with those from other species.     

苜蓿产业技术国际专利态势分析

本研究围绕苜蓿种植、加工、利用等产业链上的相关技术进行国际专利态势分析,研判苜蓿产业技术的研发态势,为促进我国饲草料研发提供参考。研究采用文献计量方法,重点针对主要技术研发领域、研发热点及重要国家、机构的研发产出和布局开展深入分析。分析表明,从20世纪90年代中期开始,苜蓿产业技术专利产出快速增加;其中,育种技术的专利申请数量及核心专利数量最多,转基因相关技术是热点研发主题;美国和中国专利数量领先,美国主要布局在育种、病虫草害防控和收获加工工艺与设备领域,中国主要布局在饲料与饲养、肥料和栽培农艺领域;重要专利申请机构主要来自美国、德国和中国。大型农业跨国公司是最主要的专利申请主体。育种、病虫草害防控和收获加工工艺与设备等领域的专利基本由大型跨国公司把控,绝大多数核心专利也基本来自大型跨国公司。研究表明,我国苜蓿领域专利研发发展迅速,但专利技术水平和专利研发布局仍有提高优化空间,应大力推动核心技术领域的研发。